US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 29.260
  • -0.320-1.08%
Close Nov 12 16:00 ET
  • 29.380
  • +0.120+0.41%
Post 17:26 ET
3.64BMarket Cap-14413P/E (TTM)

Apellis Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 12, 2024

Based on 17 analysts giving stock ratings to Apellis Pharmaceuticals in the past 3 months

Strong Buy

  • Buy

    76.47%
  • Hold

    23.53%
  • Sell

    0.00%

Price Target

Updated: Nov 12, 2024

The average Apellis Pharmaceuticals stock price target is 46.29 with a max estimate of 75.00 and a min estimate of 30.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 12, 2024

Strong Buy

  • Buy

    76.47%
  • Hold

    23.53%
  • Sell

    0.00%

Price Target

Updated: Nov 12, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data